Logo image of CTRV

Contravir Pharmaceut (CTRV) Stock Price, Quote, News and Overview

NASDAQ:CTRV - Nasdaq -

3.58  +0.02 (+0.56%)

After market: 3.62 +0.04 (+1.12%)

CTRV Quote, Performance and Key Statistics

Contravir Pharmaceut

NASDAQ:CTRV (7/22/2019, 8:22:58 PM)

After market: 3.62 +0.04 (+1.12%)

3.58

+0.02 (+0.56%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High61.6
52 Week Low3.52
Market Cap2.87M
Shares803.00K
Float347.07K
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


CTRV short term performance overview.The bars show the price performance of CTRV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

CTRV long term performance overview.The bars show the price performance of CTRV in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CTRV is 3.58 null. In the past month the price decreased by -31.15%. In the past year, price decreased by -93.09%.

Contravir Pharmaceut / CTRV Daily stock chart

About CTRV

Company Profile

ContraVir Pharmaceuticals Inc. is a biopharmaceutical company. The company is involved in the discovery and development of antiviral therapies. ContraVir Pharmaceuticals Inc. is headquartered in Edison, New Jersey.

Company Info

Contravir Pharmaceut

399 THORNALL STREET FIRST FLOOR

EDISON NJ 08837

CEO: Robert Foster

Phone: 732-902-4000

Contravir Pharmaceut / CTRV FAQ

What is the stock price of Contravir Pharmaceut today?

The current stock price of CTRV is 3.58 null. The price increased by 0.56% in the last trading session.


What is the ticker symbol for Contravir Pharmaceut stock?

The exchange symbol of Contravir Pharmaceut is CTRV and it is listed on the Nasdaq exchange.


On which exchange is CTRV stock listed?

CTRV stock is listed on the Nasdaq exchange.


What is Contravir Pharmaceut worth?

Contravir Pharmaceut (CTRV) has a market capitalization of 2.87M null. This makes CTRV a Nano Cap stock.


What are the support and resistance levels for Contravir Pharmaceut (CTRV) stock?

Contravir Pharmaceut (CTRV) has a resistance level at 4.5. Check the full technical report for a detailed analysis of CTRV support and resistance levels.


Should I buy Contravir Pharmaceut (CTRV) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Contravir Pharmaceut (CTRV) stock pay dividends?

CTRV does not pay a dividend.


What is the Price/Earnings (PE) ratio of Contravir Pharmaceut (CTRV)?

Contravir Pharmaceut (CTRV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.39).


CTRV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CTRV Financial Highlights

Over the last trailing twelve months CTRV reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -120.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -59.63%
ROE -730.21%
Debt/Equity 0.84
Chartmill High Growth Momentum
EPS Q2Q%-10407.69%
Sales Q2Q%N/A
EPS 1Y (TTM)-120.63%
Revenue 1Y (TTM)N/A

CTRV Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to CTRV. The Buy consensus is the average rating of analysts ratings from 1 analysts.


Ownership
Inst Owners1.07%
Ins Owners491.99%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y-60.6%
Revenue Next YearN/A